These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11440138)

  • 1. Aurantiamide acetate, a selective cathepsin inhibitor, produced by Aspergillus penicilloides.
    Isshiki K; Asai Y; Tanaka S; Nishio M; Uchida T; Okuda T; Komatsubara S; Sakurai N
    Biosci Biotechnol Biochem; 2001 May; 65(5):1195-7. PubMed ID: 11440138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors.
    Tsuchiya K; Kohda Y; Yoshida M; Zhao L; Ueno T; Yamashita J; Yoshioka T; Kominami E; Yamashima T
    Exp Neurol; 1999 Feb; 155(2):187-94. PubMed ID: 10072294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Z-Phe-Gly-NHO-Bz, an inhibitor of cysteine cathepsins, induces apoptosis in human cancer cells.
    Zhu DM; Uckun FM
    Clin Cancer Res; 2000 May; 6(5):2064-9. PubMed ID: 10815933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of cysteine proteinases responsible for digestive proteolysis in guts of larval western corn rootworm (Diabrotica virgifera) by expression in the yeast Pichia pastoris.
    Bown DP; Wilkinson HS; Jongsma MA; Gatehouse JA
    Insect Biochem Mol Biol; 2004 Apr; 34(4):305-20. PubMed ID: 15041015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is cathepsin K truly involved in bone resorption?
    Everts V
    J Bone Miner Res; 1998 Feb; 13(2):321-2. PubMed ID: 9495527
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppressive effect of N-(benzyloxycarbonyl)-L-phenylalanyl-L-tyrosinal on bone resorption in vitro and in vivo.
    Woo JT; Yamaguchi K; Hayama T; Kobori T; Sigeizumi S; Sugimoto K; Kondo K; Tsuji T; Ohba Y; Tagami K; Sumitani K
    Eur J Pharmacol; 1996 Apr; 300(1-2):131-5. PubMed ID: 8741178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a potent and selective non-basic cathepsin K inhibitor.
    Li CS; Deschenes D; Desmarais S; Falgueyret JP; Gauthier JY; Kimmel DB; Léger S; Massé F; McGrath ME; McKay DJ; Percival MD; Riendeau D; Rodan SB; Thérien M; Truong VL; Wesolowski G; Zamboni R; Black WC
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1985-9. PubMed ID: 16413777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.
    Montaser M; Lalmanach G; Mach L
    Biol Chem; 2002; 383(7-8):1305-8. PubMed ID: 12437121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMC-52A to D, novel cysteine proteinase inhibitors, produced by Gliocladium sp.
    Isshiki K; Nishio M; Sakurai N; Uchida T; Okuda T; Komatsubara S
    J Antibiot (Tokyo); 1998 Jul; 51(7):629-34. PubMed ID: 9727388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HEPG2 cells.
    Peppard JV; Knap AK
    In Vitro Cell Dev Biol Anim; 1999 Sep; 35(8):459-64. PubMed ID: 10501085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays.
    Ren XF; Li HW; Fang X; Wu Y; Wang L; Zou S
    Org Biomol Chem; 2013 Feb; 11(7):1143-8. PubMed ID: 23299878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
    Löser R; Gütschow M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate.
    Stroup GB; Lark MW; Veber DF; Bhattacharyya A; Blake S; Dare LC; Erhard KF; Hoffman SJ; James IE; Marquis RW; Ru Y; Vasko-Moser JA; Smith BR; Tomaszek T; Gowen M
    J Bone Miner Res; 2001 Oct; 16(10):1739-46. PubMed ID: 11585335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
    Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
    Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent nitrile-based inhibitors of cysteine cathepsins.
    Frizler M; Mertens MD; Gütschow M
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7715-8. PubMed ID: 23122525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bone resorption by selective inactivators of cysteine proteinases.
    Hill PA; Buttle DJ; Jones SJ; Boyde A; Murata M; Reynolds JJ; Meikle MC
    J Cell Biochem; 1994 Sep; 56(1):118-30. PubMed ID: 7806585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo.
    Katunuma N; Matsui A; Inubushi T; Murata E; Kakegawa H; Ohba Y; Turk D; Turk V; Tada Y; Asao T
    Biochem Biophys Res Commun; 2000 Jan; 267(3):850-4. PubMed ID: 10673380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells.
    Johansson AC; Norberg-Spaak L; Roberg K
    Acta Otolaryngol; 2006 Jan; 126(1):70-81. PubMed ID: 16308258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodioxocin-3-ones and N-acyl-3-amino-3-buten-2-ones: novel classes of cathepsin K cysteine protease inhibitors.
    Yamashita DS; Xie R; Lin H; Wang B; Shi SD; Quinn CJ; Hemling ME; Hissong C; Tomaszek TA; Veber DF
    J Pept Res; 2004 Mar; 63(3):265-9. PubMed ID: 15049838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.
    Everts V; Korper W; Hoeben KA; Jansen ID; Bromme D; Cleutjens KB; Heeneman S; Peters C; Reinheckel T; Saftig P; Beertsen W
    J Bone Miner Res; 2006 Sep; 21(9):1399-408. PubMed ID: 16939398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.